Fernando Romero-Palomo

Fernando Romero-Palomo

Auto-generated profile, based on publicly available information

Fernando Romero-Palomo

Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Journal of Virology
Verified
Journal Article
Open access
PDF file
EDEva Dervas
Eva Dervas
JHJussi Hepojoki
Jussi Hepojoki
ALAndrea Laimbacher
Andrea Laimbacher
FRFernando Romero-Palomo
Fernando Romero-Palomo
CJChristine Jelinek
Christine Jelinek
UHUdo Hetzel
Udo Hetzel
In 2014 we observed a noticeable increase in the number of sudden deaths among green tree pythons ( Morelia viridis ). Pathological examination revealed the accumulation of mucoid material within the airways and lungs in association with enlargement of the entire lung. We performed a full necropsy and histological examination on 12 affected green tree pythons from 7 different breeders to characterize the pathogenesis of this mucinous pneumonia. By histology we could show a marked hyperplasia of the airway epithelium and of faveolar type II pneumocytes. Since routine microbiological tests failed to identify a causative agent, we studied lung tissue samples from a few diseased snakes by next-generation sequencing (NGS). From the NGS data we could assemble a piece of RNA genome whose sequence was <85% identical to that of nidoviruses previously identified in ball pythons and Indian pythons. We then employed reverse transcription-PCR to demonstrate the presence of the novel nidovirus in all diseased snakes. To attempt virus isolation, we established primary cultures of Morelia viridis liver and brain cells, which we inoculated with homogenates of lung tissue from infected individuals. Ultrastructural examination of concentrated cell culture supernatants showed the presence of nidovirus particles, and subsequent NGS analysis yielded the full genome of the novel virus Morelia viridis nidovirus (MVNV). We then generated an antibody against MVNV nucleoprotein, which we used alongside RNA in situ hybridization to demonstrate viral antigen and RNA in the affected lungs. This suggests that in natural infection MVNV damages the respiratory tract epithelium, which then results in epithelial hyperplasia, most likely as an exaggerated regenerative attempt in association with increased epithelial turnover. IMPORTANCE Novel nidoviruses associated with severe respiratory disease were fairly recently identified in ball pythons and Indian pythons. Herein we report on the isolation and identification of a further nidovirus from green tree pythons ( Morelia viridis ) with fatal pneumonia. We thoroughly characterized the pathological changes in the infected individuals and show that nidovirus infection is associated with marked epithelial proliferation in the respiratory tract. We speculate that this and the associated excess mucus production can lead to the animals' death by inhibiting normal gas exchange in the lungs. The virus was predominantly detected in the respiratory tract, which renders transmission via the respiratory route likely. Nidoviruses cause sudden outbreaks with high rates of mortality in breeding collections, and most affected snakes die without prior clinical signs. These findings, together with those of other groups, indicate that nidoviruses are a likely cause of severe pneumonia in pythons.

1 November 2011 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
MRMaria A Risalde
Maria A Risalde
Veronica Molina-HernandezVeronica Molina-Hernandez
Veronica Molina-Hernandez
PSP.J. Sánchez-Cordón
P.J. Sánchez-Cordón
MPMiriam Pedrera
Miriam Pedrera
RPRosario Panadero
Rosario Panadero
JGJ.C. Gómez-Villamandos
J.C. Gómez-Villamandos

8 November 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MRMaria A Risalde
Maria A Risalde
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
FRFernando Romero-Palomo
Fernando Romero-Palomo
MFMario Frías
Mario Frías
PLPedro López-López
Pedro López-López
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
Hepatitis E virus (HEV) is an emerging zoonotic pathogen with pigs and wild boar serving as reservoirs for human infection through direct contact with infected animals or the consumption of raw or undercooked pork products. The liver is considered the main target site of HEV replication in swine and an important organ in the pathogenesis of the disease. The aim of this study was to characterize the target liver cells for HEV entry in naturally infected wild boar and to evaluate the type and severity of the pathological changes in order to reach a better understanding of the hepatic pathogenic mechanisms involved in hepatitis E. In total, 58 livers from hunted wild boar were histopathologically evaluated. The presence of specific HEV antibodies in serum was determined by indirect ELISA. Immunohistochemistry was used for the detection of HEV antigen and Real time RT-PCR to detect HEV RNA in liver and serum. HEV seroprevalence in these animals was of 5.197% (CI95%: 1.77–14.14). By Real time RT-PCR, HEV was detected in the liver tissue of four wild boar (6.8%; CI95%: 2.7–16.4) and only one animal was also positive in serum (1.7%; CI95%: 0.3–9.1). The non-viremic animals naturally infected with HEV presented evidence of liver infection, mainly in Kupffer cells and liver sinusoidal endothelial cells, without apparent associated hepatitis lesions. This study supports the hypothesis that low viral titers may persist in the liver of non-viremic individuals, giving thus the possibility of consumption of contaminated liver of animals diagnosed as HEV-negative in serum. Further immunopathogenic studies are necessary to elucidate the mechanisms responsible for this process and to evaluate the protocols of HEV diagnosis in animals destined for human consumption.

18 March 2013 in Veterinary Research
Verified
Journal Article
Open access
PDF file
MRMaria A Risalde
Maria A Risalde
Veronica Molina-HernandezVeronica Molina-Hernandez
Veronica Molina-Hernandez
PSPedro J Sánchez-Cordón
Pedro J Sánchez-Cordón
FRFernando Romero-Palomo
Fernando Romero-Palomo
MPMiriam Pedrera
Miriam Pedrera
JGJosé C Gómez-Villamandos
José C Gómez-Villamandos
Resistance to respiratory disease in cattle requires host defense mechanisms that protect against pathogens which have evolved sophisticated strategies to evade them, including an altered function of pulmonary macrophages (MΦs) or the induction of inflammatory responses that cause lung injury and sepsis. The aim of this study was to clarify the mechanisms responsible for vascular changes occurring in the lungs of calves infected with bovine viral diarrhea virus (BVDV) and challenged later with bovine herpesvirus type 1 (BHV-1), evaluating the role of MΦs in the development of pathological lesions in this organ. For this purpose, pulmonary lesions were compared between co-infected calves and healthy animals inoculated only with BHV-1 through immunohistochemical (MAC387, TNFα, IL-1α, iNOS, COX-2 and Factor-VIII) and ultrastructural studies. Both groups of calves presented important vascular alterations produced by fibrin microthrombi and platelet aggregations within the blood vessels. These findings were earlier and more severe in the co-infected group, indicating that the concomitance of BVDV and BHV-1 in the lungs disrupts the pulmonary homeostasis by facilitating the establishment of an inflammatory and procoagulant environment modulated by inflammatory mediators released by pulmonary MΦs. In this regard, the co-infected calves, in spite of presenting a greater number of IMΦs than single-infected group, show a significant decrease in iNOS expression coinciding with the presence of more coagulation lesions. Moreover, animals pre-inoculated with BVDV displayed an alteration in the response of pro-inflammatory cytokines (TNFα and IL-1), which play a key role in activating the immune response, as well as in the local cell-mediated response.

1 June 2021 in Toxicologic Pathology
Verified
Journal Article
Closed access
PDF file
FRFernando Romero-Palomo
Fernando Romero-Palomo
MFMatthias Festag
Matthias Festag
BLBarbara Lenz
Barbara Lenz
SSSimone Schadt
Simone Schadt
ABAndreas Brink
Andreas Brink
ABAnnamaria Braendli-Baiocco
Annamaria Braendli-Baiocco
Antisense oligonucleotides (ASOs) are chemically modified nucleic acids with therapeutic potential, some of which have been approved for marketing. We performed a study in rats to investigate mechanisms of toxicity after administration of 3 tool locked nucleic acid (LNA)-containing ASOs with differing established safety profiles. Four male rats per group were dosed once, 3, or 6 times subcutaneously, with 7 days between dosing, and sacrificed 3 days after the last dose. These ASOs were either unconjugated (naked) or conjugated with N-acetylgalactosamine for hepatocyte-targeted delivery. The main readouts were in-life monitoring, clinical and anatomic pathology, exposure assessment and metabolite identification in liver and kidney by liquid chromatography coupled to tandem mass spectrometry, ASO detection in liver and kidney by immunohistochemistry, in situ hybridization, immune electron microscopy, and matrix-assisted laser desorption/ionization mass spectrometry imaging. The highly toxic compounds showed the greatest amount of metabolites and a low degree of tissue accumulation. This study reveals different patterns of cell death associated with toxicity in liver (apoptosis and necrosis) and kidney (necrosis only) and provides new ultrastructural insights on the tissue accumulation of ASOs. We observed that the immunostimulatory properties of ASOs can be either primary from sequence-dependent properties or secondary to cell necrosis.

5 September 2012 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
Veronica Molina-HernandezVeronica Molina-Hernandez
Veronica Molina-Hernandez
MRMaria A Risalde
Maria A Risalde
PSP. J. Sánchez-Cordón
P. J. Sánchez-Cordón
FRF. Romero-Palomo
F. Romero-Palomo
MPMiriam Pedrera
Miriam Pedrera
JGJ. C. Gómez-Villamandos
J. C. Gómez-Villamandos
Acute infections with bovine viral diarrhoea virus (BVDV), a major pathogen of cattle, are often asymptomatic or produce only mild clinical symptoms. However, they may play an important role in the bovine respiratory disease complex by exerting a marked immunosuppressive effect, as a result of the death of the immunocompetent cell populations involved in controlling innate and adaptive immune responses, together with a marked reduction of both cytokine expression and co‐stimulatory molecule synthesis. Although experimental research and field studies have shown that acute BVDV infection enhances susceptibility to secondary infection, the precise mechanism involved in BVDV‐induced immunosuppression remains unclear. The present study is aimed at measuring a range of blood parameters in a single group of fourteen calves infected with non‐cytopathic BVDV‐1. Focus has been put on those related to the cell‐mediated immune response just as leucocyte populations and lymphocyte subpopulations, serum concentrations of cytokines (IL‐1β, TNF‐α, IFN‐γ, IL‐12, IL‐4 and IL‐10) and acute phase proteins [haptoglobin, serum amyloid A (SAA), fibrinogen and albumin], as well as BVDV‐specific antibodies and viremia. After non‐cytopathic BVDV‐1 infection, clinical signs intensity was never more than moderate coinciding with the presence of viremia and leucocyte and lymphocyte depletion. An early increase in TNF‐α, IFN‐γ and IL‐12 levels in contrast to IL‐1β was observed in line with a raise in haptoglobin and SAA levels on the latest days of the study. As regards IL‐4 levels, no evidence was found of any changes. However, a slight increase in IL‐10 was observed, matching up the TNF‐α decline during the acute phase response. These findings would help to increase our knowledge of the immune mechanisms involved in acute infection with non‐cytopathic BVDV‐1 strains, suggesting the existence of a clear tendency towards a type 1 immune response, thereby enhancing resistance against viral infections.